期刊文献+

预测宫颈癌患者严重放射性肠道并发症的剂量测定因素:外部宫旁剂量与累积直肠剂量的联合效应

Dosimetric factors predictin g severe radia-tion-induced bowel complications in pa-tients with cervical cancer:Combined effect of external parametrial dose and cumulative rectal dose
下载PDF
导出
摘要 The purpose of this study was to analy ze dosimetric factors of radiation -induced severe bowel c omplications among patients with cervical cancer.We re viewed 297patients of stage IB -IVA cervical cancer manage d by curative -in-tent radiotherapy from May 1993thro ugh December 1997.Whole -pelvic irradiation of extern al beam radiation ther-apy(EBRT)(34.2-48.6Gy /19-27fractions)was delivered to all patients.Two hundr ed and three patients received additional bilateral para metrial boost(3.6-18Gy /2-10fractions).High dose -rate(HDR)intracavi-tary brachytherapy(ICBT),16-24Gy /5fractions toPoint A,was given after external irradiation.Cumulative rectal biologically effective dose(CRBED)at rectal refer-ence point was determined by summation of EBRT and ICBT component.The 5-year incidences of Grade 3-4enterocolitis and proctitis were 10%and 7%,respective-ly.Both complications were associa ted with external parametrial dose(PMD)and CRBED.Interaction of CRBED and PMD was noted in multivaria te analysis of enterocolitis(P<0.001)and proctitis(P<0.001).In CRBED≥100Gy 3 group,PMD was an independent factor in enterocolitis(P =0.010)and proctitis(P =0.039).In PMD≥54Gy group,CRBED was an independent factor in enterocolitis(P =0.003)-and proctitis(P =0.036).Patients with both PMD≥54Gy and CRBED≥100Gy 3 had higher incidence of 5-year enterocolitis(26%)(P<0.001)and proctitis(17%)(P<0.001)than other dose groups.Radiation -i nduced severe bowel complications are association on both high PMD and high CRBED.We do not suggest both external PMD≥54Gy and CRBED≥100Gy 3 for treatment of cervical cancer due to unacceptably high incidence o f severe bowel com-plications. The purpose of this study was to analy ze dosimetric factors of radiation -induced severe bowel c omplications among patients with cervical cancer.We re viewed 297patients of stage IB -IVA cervical cancer manage d by curative -in-tent radiotherapy from May 1993thro ugh December 1997.Whole -pelvic irradiation of extern al beam radiation ther-apy(EBRT)(34.2-48.6Gy /19-27fractions)was delivered to all patients.Two hundr ed and three patients received additional bilateral para metrial boost(3.6-18Gy /2-10fractions).High dose -rate(HDR)intracavi-tary brachytherapy(ICBT),16-24Gy /5fractions toPoint A,was given after external irradiation.Cumulative rectal biologically effective dose(CRBED)at rectal refer-ence point was determined by summation of EBRT and ICBT component.The 5-year incidences of Grade 3-4enterocolitis and proctitis were 10%and 7%,respective-ly.Both complications were associa ted with external parametrial dose(PMD)and CRBED.Interaction of CRBED and PMD was noted in multivaria te analysis of enterocolitis(P<0.001)and proctitis(P<0.001).In CRBED≥100Gy 3 group,PMD was an independent factor in enterocolitis(P =0.010)and proctitis(P =0.039).In PMD≥54Gy group,CRBED was an independent factor in enterocolitis(P =0.003)-and proctitis(P =0.036).Patients with both PMD≥54Gy and CRBED≥100Gy 3 had higher incidence of 5-year enterocolitis(26%)(P<0.001)and proctitis(17%)(P<0.001)than other dose groups.Radiation -i nduced severe bowel complications are association on both high PMD and high CRBED.We do not suggest both external PMD≥54Gy and CRBED≥100Gy 3 for treatment of cervical cancer due to unacceptably high incidence o f severe bowel com-plications.
出处 《世界核心医学期刊文摘(妇产科学分册)》 2005年第2期57-58,共2页 Core Journal in Obstetrics/Gynecology
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部